Ambrx Biopharma Revenue 2020-2023 | AMAM
Ambrx Biopharma revenue from 2020 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Ambrx Biopharma Annual Revenue
(Millions of US $) |
| 2022 |
$7 |
| 2021 |
$7 |
| 2020 |
$14 |
| 2019 |
$10 |
Ambrx Biopharma Quarterly Revenue
(Millions of US $) |
| 2023-03-31 |
$0 |
| 2022-12-31 |
|
| 2022-06-30 |
|
| 2022-03-31 |
$2 |
| 2021-12-31 |
|
| 2021-06-30 |
|
| 2020-12-31 |
|
| 2019-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.824B |
$0.007B |
|
Ambrx Biopharma Inc. is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. Ambrx Biopharma Inc. is based in SAN DIEGO.
|
